The relationship between the myocardial kinetics of meperidine and its effect on myocardial contractility: Model-independent analysis and optimal regional model

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 2, 1999, Pages 694-701

  Upton, Richard N ^a   Huang, Yi Fei ^a,c   Mather, Laurence E ^b,c   Doolette, David J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PETHIDINE;

ANIMAL EXPERIMENT; ARTERIAL BLOOD; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; CORONARY SINUS BLOOD FLOW; DISTRIBUTION VOLUME; DRUG EFFECT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; SHEEP; STEADY STATE; VENOUS BLOOD;

ALGORITHMS; ANALGESICS, OPIOID; ANIMALS; CORONARY CIRCULATION; FEMALE; HEART; MALE; MEPERIDINE; MODELS, BIOLOGICAL; MYOCARDIAL CONTRACTION; SHEEP;

EID: 0344848583     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Beek WJ and Muttzall KMK (1975) Transport Phenomena, Wiley, London.
2. Bjorkman S, Wada DR, Stanski DR and Ebling WF (1994) Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models. J Pharmacokinet Biopharm 22:381-410.
3. Davia NR and Mapleson WW (1993) A physiological model for the distribution of injected agents, with special reference to pethidine. Br J Anaesth 70:248-258.
4. Gabrielsson JL, Johansson P, Bondesson U, Karlsson M and Paalzow LK (1986) Analysis of pethidine disposition in the pregnant rat by means of a physiological flow model. J Pharmacokinet Biopharm 14:381-395.
5. Gardner MJ and Altaian DG (1989) Statistics with Confidence - Confidence Intervals and Statistical Guidelines. British Medical Journal, London.
6. Huang YF, Upton RN and Mather LE.(1994b) The hemodynamic effects of i.v. bolus doses of meperidine in conscious sheep. Anesth Analg 78:442-449.
7. Huang YF, Upton RN and Runciman WB (1993) Intravenous bolus administration of subconvulsive doses of lignocaine to conscious sheep. Relationships between myocardial pharmacokinetics and pharmacodynamics. Br J Anaesth 70:556-561.
8. Huang YF, Upton RN, Rutten A and Mather LE (1994a) The myocardial pharmacokinetics of meperidine in conscious sheep. Anesth Analg 79:987-992.
9. Huang YF, Upton RN, Zheng D, McLean C, Gray EC and Grant C (1998) The enantiomer specific kinetics and dynamics of verapamil after rapid i.v. administration to sheep - Physiological analysis and modeling. J Pharm Exp Ther 284: 1048-1057.
10. Jacquez JA (1987) Identifiability: The first step in parameter estimation. Fed Proc 46:2477-2480.
11. Jones ME and Nicholas TE (1984) Limitations of Zilversmit approach to analysis of precursor-product relationships. J Appl Physiol 57:892-898.
12. Krejcie TC, Jacquez JA, Avram MJ, Niemann CU, Shanks CA and Henthorn TK (1996) Use of parallel Erlang density functions to analyze first-pass pulmonary uptake of multiple indicators in dogs. J Pharmacokinet Biopharm 24:569-588.
13. Rendig SV, Amsterdam EA, Henderson GL and Mason DT (1980) Comparative cardiac contractile actions of six narcotic analgesics: Morphine, meperidine, pentazocine, fentanyl, methadone and l-α-acetylmethadol (LAAM). J Pharmacol Exp Ther 215:259-265.
14. Rescigno A and Segre G (1996) Drug and Tracer Kinetics, Blaisdell Publishing Company, Waltham, Massachusetts.
15. Roberts MS, Donaldson JD and Rowland M (1988) Models of hepatic elimination: Comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination. J Pharmacokinet Biopharm 16:41-83.
16. Upton RN (1994) Toward target organ drug concentrations - Application of mass balance principles. Anesth Pharmacol Rev 2:231-242.
17. Upton RN, Huang YF, Grant C, Gray EC and Ludbrook GL (1996) The myocardial pharmacokinetics of thiopental in sheep after short term administration -Relationship to thiopental induced reductions in myocardial contractility. J Pharm Sci 85:863-867.
18. Upton RN, Mather LE, Runciman WB, Nancarrow C and Carapetis RJ (1988) The use of mass balance principles to describe regional drug distribution and elimination. J Pharmacokinet Biopharm 16:13-29.
19. Wagner JG (1975) Do you need a pharmacokinetic model, and, if so, which one? J Pharmacokinet Biopharm 3:457-478.
20. Wu C, Fry CH and Henry J (1997) The mode of action of several opioids on cardiac muscle. Exp Physiol 82:261-272.